Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry.
Kara BeliardOsagie A EbekozienCarla Demeterco-BerggrenGuy Todd AlonsoMary Pat GallagherMark ClementsRobert RapaportPublished in: Journal of diabetes (2020)
Highlights Our multicenter study reports a higher proportion of diabetic ketoacidosis presentation of over 60% in newly diagnosed patients with type 1 diabetes with or without confirmed coronavirus disease 2019 (COVID-19) at diagnosis. This finding is suggestive of delays in seeking care during the COVID-19 pandemic.
Keyphrases
- coronavirus disease
- newly diagnosed
- type diabetes
- respiratory syndrome coronavirus
- sars cov
- healthcare
- case report
- public health
- mental health
- cardiovascular disease
- glycemic control
- electronic health record
- insulin resistance
- quality improvement
- emergency department
- metabolic syndrome
- adverse drug
- wound healing
- deep learning
- affordable care act